IL-11 antagonist suppresses Th17 cell-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Clinical Immunology
- Vol. 197, 45-53
Abstract
No abstract availableKeywords
Funding Information
- National Center for Advancing Translational Sciences (NCATS)
- National Institutes of Health (UL1TR001111)
- NCI (2-P30-CA016086-40)
- NIEHS (2-P30ES010126-15A1)
- UCRF, and NCBT (2015-IDG-1007)
This publication has 63 references indexed in Scilit:
- DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical ImplicationsMultiple Sclerosis International, 2013
- Fully automated rodent brain MR image processing pipeline on a Midas server: from acquired images to region-based statisticsFrontiers in Neuroinformatics, 2013
- Essential Role for IL-27 Receptor Signaling in Prevention of Th1-Mediated Immunopathology during Malaria InfectionThe Journal of Immunology, 2010
- TGF-β and Regulatory T Cell in Immunity and AutoimmunityJournal of Clinical Immunology, 2008
- Multiple sclerosis: a complicated picture of autoimmunityNature Immunology, 2007
- Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17–producing human T helper cellsNature Immunology, 2007
- Diffusion Tensor Imaging of the BrainNeurotherapeutics, 2007
- Experimental Autoimmune Encephalomyelitis in the MouseCurrent Protocols in Immunology, 2007
- Mechanisms of Immune Injury in Multiple SclerosisBrain Pathology, 1996
- Molecular cloning and expression of an IL-6 signal transducer, gp130Cell, 1990